RION

RION

MN - Rochester
Biotechnology

Focus: Exosome Therapeutics

RION is a life sciences company focused on Exosome Therapeutics.

CardiovascularUnknown
Funding Stage
PUBLIC
Employees
201-500
Open Jobs
1

Pipeline & Clinical Trials

Phase 1
Clinical Trials (1)
NCT06463132Phase 1b Clinical Trial to Evaluate PEP and EUFLEXXA for Knee Osteoarthritis (KOA)
Phase 1
Clinical Trials (1)
NCT04327635Safety Evaluation of Intracoronary Infusion of Extracellular Vesicles in Patients Following Coronary Stent Implantation
Phase 1
10% PEP
Skin Graft
Phase 1
Clinical Trials (1)
NCT04664738PEP on a Skin Graft Donor Site Wound
Phase 1
Phase 1/2
Clinical Trials (1)
NCT06793748Study to Evaluate the Safety, Tolerability, and Efficacy of PEP-TISSEEL in Subjects With Chronic Radiation Ulcer
Phase 1/2
Clinical Trials (1)
NCT06319287Phase 2a Multi-Center Prospective, Randomized Trial to Evaluate the Safety & Efficacy of Topical PEP-TISSEEL for Diabetic Foot Ulcers (DFU)
Phase 2

Open Jobs (1)

Interview Prep Quick Facts
Portfolio: 5 clinical trials
Open Roles: 1 active job